With the Allergan acquisition, we are bringing together over 30
brands and leadership positions to expand and diversify our product
portfolio, whilst advance our innovative science pipeline that brings
patients ground breaking medicines across a wide spectrum of
therapeutic need/critical therapeutic areas.
We continue to build a sustainable company for the long term that
will continue to make a remarkable impact on people’s lives. The
acquisition of Allergan is a transformative move for AbbVie that will
expand our reach to help address the needs of people and communities
around the world.